Improving directional hearing of cochlear implant users

Completed

• Conditions: Deafness; sensorineural hearing loss; 10019243

• Registration Number: NL-OMON49290
• Lead Sponsor: eids Universitair Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2022-09-20
• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 18

Inclusion Criteria

CI users: measurable residual hearing in the contralateral ear with thresholds
of 100 dB HL or better at 125, 250 and 500 Hz

Normal-hearing group: not more than 40 dB loss across frequencies

Exclusion Criteria

CI users and normal-hearing subjects should have no disorders other than a
hearing impairment that could affect the study results, such as psychiatric
disorders or physical disorders that would limit their ability to undergo
testing (e.g., movement disorders or blindness).

Normal-hearing subjects will be excluded if hearing thresholds are too high.

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Speech understanding in quiet and in noise (speech-reception threshold, or %<br /><br>correct)</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Directional sensitivity (in degrees)</p><br>